1. Home
  2. SWTX vs AIN Comparison

SWTX vs AIN Comparison

Compare SWTX & AIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SWTX
  • AIN
  • Stock Information
  • Founded
  • SWTX 2017
  • AIN 1895
  • Country
  • SWTX United States
  • AIN United States
  • Employees
  • SWTX N/A
  • AIN N/A
  • Industry
  • SWTX Biotechnology: Pharmaceutical Preparations
  • AIN Textiles
  • Sector
  • SWTX Health Care
  • AIN Consumer Discretionary
  • Exchange
  • SWTX Nasdaq
  • AIN Nasdaq
  • Market Cap
  • SWTX 2.8B
  • AIN 2.5B
  • IPO Year
  • SWTX 2019
  • AIN 1987
  • Fundamental
  • Price
  • SWTX $34.63
  • AIN $81.39
  • Analyst Decision
  • SWTX Strong Buy
  • AIN Buy
  • Analyst Count
  • SWTX 6
  • AIN 4
  • Target Price
  • SWTX $68.83
  • AIN $80.75
  • AVG Volume (30 Days)
  • SWTX 1.5M
  • AIN 213.5K
  • Earning Date
  • SWTX 02-25-2025
  • AIN 02-24-2025
  • Dividend Yield
  • SWTX N/A
  • AIN 1.29%
  • EPS Growth
  • SWTX N/A
  • AIN 1.31
  • EPS
  • SWTX N/A
  • AIN 3.20
  • Revenue
  • SWTX $135,487,000.00
  • AIN $1,267,294,000.00
  • Revenue This Year
  • SWTX $3,413.86
  • AIN $9.50
  • Revenue Next Year
  • SWTX $88.52
  • AIN $4.61
  • P/E Ratio
  • SWTX N/A
  • AIN $25.42
  • Revenue Growth
  • SWTX N/A
  • AIN 15.93
  • 52 Week Low
  • SWTX $28.21
  • AIN $67.39
  • 52 Week High
  • SWTX $53.92
  • AIN $98.73
  • Technical
  • Relative Strength Index (RSI)
  • SWTX 43.67
  • AIN 52.99
  • Support Level
  • SWTX $31.96
  • AIN $79.95
  • Resistance Level
  • SWTX $44.01
  • AIN $82.33
  • Average True Range (ATR)
  • SWTX 3.20
  • AIN 2.12
  • MACD
  • SWTX -0.47
  • AIN 0.13
  • Stochastic Oscillator
  • SWTX 19.53
  • AIN 76.00

About SWTX SpringWorks Therapeutics Inc.

SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.

About AIN Albany International Corporation

Albany International Corp is principally engaged in processing textiles and materials. The company consists of two business segments, the machine clothing segment, which produces and provides custom-designed fabrics and belts for the production in the paper, nonwovens, and other process industries; and the Albany engineered composites segment, which offers engineered composite parts for the aerospace and defensive industries. The machine clothing segment contributes to the majority of the company's total revenue. The company has an operation and generates revenue from the United States, Switzerland, Brazil, China, Mexico, France, and other areas.

Share on Social Networks: